JAMA at AHA, Review of MASLD, Primary Biliary Cholangitis, and more

JAMA at AHA, Review of MASLD, Primary Biliary...

Up next

From the JAMA Network: JAMA Research of the Year With Editor in Chief Kirsten Bibbins-Domingo

In this episode, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, and Medical News Director Jennifer Abbasi discuss the journal's inaugural Research of the Year roundup. Related Content: Research of the Year 2025 

COVID-19 Vaccine and Pregnancy Outcomes, Valacyclovir for Alzheimer Disease, Abortion Access in Los Angeles, and more

Editor's Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief, and Preeti Malani, MD, MSJ, Deputy Editor of JAMA, the Journal of the American Medical Association, for articles published from December 13-19, 2025. 

Recommended Episodes

Geroscience in Medicine
JAMA Clinical Reviews

Geroscience aims to define and modify biologic pathways associated with aging and age-related diseases. Author Stephen B. Kritchevsky, PhD, of the Wake Forest University School of Medicine and JAMA Deputy Editor Mary M. McDermott, MD, discuss current evidence regarding geroscienc ...  Show more

Ophthalmology Reviews: A New Frontier in the Ophthalmology Family of Journals
Ophthalmology Journal

Ophthalmology Editor-in-Chief, Russell Van Gelder, MD, PhD, and our new Associate Editor, Laura Downie, BOptom, PhD, guest host this special episode introducing "Ophthalmology Reviews." <span style= "mso-spacerun: yes;"> </span>Ophthalmology Reviews ...

  Show more

Diagnosis and Management of Prostatitis
JAMA Clinical Reviews

Prostatitis affects approximately 9.3% of men in their lifetime and includes acute and chronic bacterial infection and nonbacterial chronic prostatitis with chronic pelvic pain syndrome. Author Minh N. Pham, MD, from University of North Carolina School of Medicine discusses this ...  Show more

Time to Significant Benefit of Finerenone in Patients with Heart Failure | HFSA 2024
JACC This Week

Michelle M Kittleson, MD, FACC, JACC Associate Editor, speaks with author Muthiah Vaduganathan, MD on his accepted paper concerning the FINEARTS trial published in JACC.